Evaluation of potential drug–drug interactions with medical cannabis
Clinical and Translational Science · 2024-05 · 17 (5)
DOI: 10.1111/cts.13812 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Clinical and Translational Science, online erschienen am 08.05.2024. Verfasst von Jessie Jia Yi Ho und 4 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, Monash University Malaysia, Bandar Sunway, Selangor, Malaysia. Hauptthemen laut MEDLINE: Anticonvulsants, Drug Interactions, Medical Marijuana. Die Arbeit wurde bisher 33-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Cannabis–drug interactions have caused significant concerns, mainly due to their role in the cytochrome P450 (CYP) enzyme‐mediated metabolic pathway of numerous medications. A systematic review was conducted to gain an overview of the potential interactions of cannabis with different drug classes by extracting pertinent information from published study data. From the inception of the study to October 1, 2023, we performed a systematic search of PubMed, Scopus, clinicaltrials.gov , and Web of Science. We included 54 out of 464 articles, and a total of 20 drug classes were identified to have interactions with medicinal cannabis. The cannabis–drug interactions were assessed and classified according to their probability and severity. The analysis revealed that antiepileptics had the most evidence of interaction with cannabis, followed by clobazam (CLB), warfarin, and tacrolimus. Generally, cannabis–drug interactions result in pharmacokinetic (PK) or pharmacodynamic (PD) changes. Therefore, careful monitoring should be performed to detect any unusual elevations in plasma levels. In addition, dose titrations or treatment withdrawal could help mitigate the adverse effects attributed to cannabis–drug interactions. Nevertheless, novel drugs are constantly emerging, and more research is needed to further identify potential interactions with cannabis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- School of Pharmacy, Monash University Malaysia, Bandar Sunway, Selangor, Malaysia.
ORCID-Profile: Jessie Jia Yi Ho, Chenyi Goh, Caitlin Shen Ai Leong, Khuen Yen Ng, Athirah Bakhtiar
Zitieren
APA
Ho, J. J. Y., Goh, C., Leong, C. S. A., Ng, K. Y., & Bakhtiar, A. (2024). Evaluation of potential drug–drug interactions with medical cannabis. Clinical and Translational Science, 17(5). https://doi.org/10.1111/cts.13812
Vancouver
Ho JJY, Goh C, Leong CSA, Ng KY, Bakhtiar A. Evaluation of potential drug–drug interactions with medical cannabis. Clinical and Translational Science. 2024;17(5). doi:10.1111/cts.13812
BibTeX
@article{Ho2024,
author = {Ho, Jessie Jia Yi and Goh, Chenyi and Leong, Caitlin Shen Ai and Ng, Khuen Yen and Bakhtiar, Athirah},
title = {Evaluation of potential drug–drug interactions with medical cannabis},
journal = {Clinical and Translational Science},
year = {2024},
volume = {17},
number = {5},
doi = {10.1111/cts.13812}
}
EUVIMED